Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

14.60

+0.23 (1.60%)

At close: Mar 26, 2026, 4:00 PM EDT

14.45

-0.15 (-1.03%)

Pre-market: Mar 27, 2026, 7:25 AM EDT

Aurinia Pharmaceuticals Employees

Aurinia Pharmaceuticals had 128 employees as of December 31, 2025. The number of employees decreased by 2 or -1.54% compared to the previous year.

Employees

128

Change (1Y)

-2

Growth (1Y)

-1.54%

Revenue / Employee

$2,211,367

Profits / Employee

$2,243,766

Market Cap

1.94B

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	128	-2	-1.54%
Dec 31, 2024	130	-170	-56.67%
Dec 31, 2023	300	0	-
Dec 31, 2022	300	0	-
Dec 31, 2021	300	6	2.04%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
Zai Lab	1,784
Ultragenyx Pharmaceutical	1,371
ADMA Biologics	647
Ascentage Pharma Group International	605
Galapagos NV	558
Stoke Therapeutics	170
Definium Therapeutics	106
AnaptysBio	104